Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia E Maxson

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Blood|April 8, 2021
A new role for hematoxylin: targeting CALRJulia E Maxson
Blood|December 29, 2016
Genomics of chronic neutrophilic leukemiaJulia E Maxson, Jeffrey W Tyner
Blood|November 26, 2008
Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cellsJulia E Maxson, Caroline A Enns, An-Sheng Zhang
The Journal of Biological Chemistry|October 13, 2010
Matriptase-2- and proprotein convertase-cleaved forms of hemojuvelin have different roles in the down-regulation of hepcidin expressionJulia E Maxson, Juxing Chen, Caroline A Enns, et al.
Blood|July 31, 2013
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatmentJason Gotlib, Julia E Maxson, Tracy I George, et al.
Haematologica|December 29, 2022
A novel colony stimulating factor 3 receptor activating mutation identified in a patient with chronic neutrophilic leukemiaBreanna N Maniaci, Jooho Chung, Pedro Sanz-Altamira, et al.
Biomarker Research|January 31, 2021
Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case reportSarah A Carratt, Diana Brewer, Julia E Maxson, et al.
Leukemia Research Reports|January 29, 2015
Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndromeTheodore P Braun, Julia E Maxson, Anupriya Agarwal, et al.
The Journal of Biological Chemistry|April 14, 2016
Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the LiverNingning Zhao, Julia E Maxson, Richard H Zhang, et al.
Leukemia|December 18, 2019
Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapyRyan C Stoner, Richard D Press, Julia E Maxson, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Blood|April 8, 2021
A new role for hematoxylin: targeting CALRJulia E Maxson
Blood|December 29, 2016
Genomics of chronic neutrophilic leukemiaJulia E Maxson, Jeffrey W Tyner
Blood|November 26, 2008
Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cellsJulia E Maxson, Caroline A Enns, An-Sheng Zhang
The Journal of Biological Chemistry|October 13, 2010
Matriptase-2- and proprotein convertase-cleaved forms of hemojuvelin have different roles in the down-regulation of hepcidin expressionJulia E Maxson, Juxing Chen, Caroline A Enns, et al.
Blood|July 31, 2013
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatmentJason Gotlib, Julia E Maxson, Tracy I George, et al.
Haematologica|December 29, 2022
A novel colony stimulating factor 3 receptor activating mutation identified in a patient with chronic neutrophilic leukemiaBreanna N Maniaci, Jooho Chung, Pedro Sanz-Altamira, et al.
Biomarker Research|January 31, 2021
Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case reportSarah A Carratt, Diana Brewer, Julia E Maxson, et al.
Leukemia Research Reports|January 29, 2015
Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndromeTheodore P Braun, Julia E Maxson, Anupriya Agarwal, et al.
The Journal of Biological Chemistry|April 14, 2016
Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the LiverNingning Zhao, Julia E Maxson, Richard H Zhang, et al.
Leukemia|December 18, 2019
Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapyRyan C Stoner, Richard D Press, Julia E Maxson, et al.
Pageof 5